October 23 2024 - Merck sets sights on brain cancer with $30M Modifi acquisition

Merck sets sights on brain cancer with $30M Modifi acquisition
Boston Scientific, Edwards and Dexcom usher in second week of device earnings
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
Regeneron loses bid to block Amgen's Eylea biosimilar launch in US
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*